氮芥

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 海关数据
  • 结构与计算化学
  • 上游产品
  • 下游产品

氮芥 基本信息

中文名称:
氮芥 
中文别名:
氮芥;
双(2-氯乙基)甲胺 
英文名称:
Chlormethine
英文别名:
mechlorethamine;
Bis(2-chloroethyl)methylamine;
Caryolysine;
methyl-bis-(2-chloro-ethyl)-amine;
Chlorethazine;
Mustargen;
Embichin;
Nitrogranulogen;
Mustine;
2-chloro-N-(2-chloroethyl)-N-methylethanamine;
Nitrogen mustard;
Chlormethine;
N,N-bis(2-chloroethyl)methylamine;
N-methyl-bis-(2-chloroethyl)amine 
CAS No.:
51-75-2
分 子 式:
C5H11Cl2N
分 子 量:
156.05
精确分子量:
155.02700
PSA:
3.24000
EINECS:
200-120-5
InChI:
The Key: HAWPXGHAZFHHAD-UHFFFAOYSA-N
风险术语:
R11; R20/22; R24; R34
分子结构式:
SDS:
查看

氮芥 制备方法及用途

制备方法

由二乙醇胺经甲酸,甲醛甲基化,氯化亚砜氯化而得。

合成制备方法

由二乙醇胺经甲酸,甲醛甲基化,氯化亚砜氯化而得。

用途简介

盐酸氮芥(C5H11CI2N·HCI,[55-86-7]是抗恶性肿瘤药。该品直接与DNA结合,影响其结构和功能,具有强烈的细胞毒作用,选择性差,对增殖细胞和非增殖细胞的作用近似。主要用于恶性淋巴瘤和蕈样肉芽肿以及肺癌,对未分化癌疗效好而快,与VCR、甲基苄肼等合用治疗何杰金氏病有较高的疗效。对卵巢癌、乳腺癌、绒癌、前列腺癌、精原细胞癌和鼻咽癌(半身化疗法)等也有一定的疗效。也可用作植物育种诱变剂。盐酸氮芥对粘膜有强烈刺激作用。

氮芥 物化性质

外观与性状:
非固定的液体
密度:
1.106g/cm3
熔点:
-60ºC
沸点:
110.3ºC at 760mmHg
闪点:
20.5ºC
折射率:
1.455
存储条件/存储方法:
库房通风低温干燥,与食品原料分开存放
其它信息:

1.性状:易流动的液体。

2.熔点(℃):-60。

3.沸点(℃):86-87(1.46kPa),59℃(0.266kPa)。

4.相对密度:1.118(25/4℃)。

5.溶解性:微溶于水,可与DMF、CS2、CCI4等有机溶剂混溶。

氮芥 安全信息

包装等级:
II
风险类别:
6.1(a)
海关代码:
2921194000
WGK_Germany:
3
德国有关水污染物质的分类清单
危险类别码:
R11:Highly Flammable. R20/22:Harmful by inhalation and if swallowed . R24:Toxic in contact with skin. R34:Causes burns.
安全说明:
S16:Keep away from sources of ignition - No smoking . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . S45:In case of accident
RTECS号:
UC6650000
危险标志:
F,T

氮芥 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
IA1750000
CHEMICAL NAME :
Diethylamine, 2,2'-dichloro-N-methyl-
CAS REGISTRY NUMBER :
51-75-2
BEILSTEIN REFERENCE NO. :
0605323
LAST UPDATED :
199806
DATA ITEMS CITED :
161
MOLECULAR FORMULA :
C5-H11-Cl2-N
MOLECULAR WEIGHT :
156.07
WISWESSER LINE NOTATION :
G2N1&2G

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
12 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
860 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1200 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1100 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intracerebral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
125 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1700 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
29 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2400 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2600 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD65 - Lethal Dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Primate - monkey
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LCLo - Lowest published lethal concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
290 mg/m3/10M
TOXIC EFFECTS :
Behavioral - irritability Lungs, Thorax, or Respiration - other changes
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
5 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
12 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
3 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1600 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
12 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
2 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - acute pulmonary edema
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Bird - pigeon
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Bird - chicken
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - domestic
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Mammal - domestic
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
153 mg/kg/3Y-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
5840 mg/kg/8Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5720 ug/kg/1Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Gastrointestinal - tumors Blood - leukemia
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
60 mg/kg/14W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
69 mg/kg/39W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg/42D-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Blood - leukemia Blood - lymphoma, including Hodgkin's disease
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
276 mg/kg/23W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - hair Skin and Appendages - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
256 mg/kg/8.5Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
300 ug/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
300 ug/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
800 ug/kg
SEX/DURATION :
female 4 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
1 mg/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - cytological changes (including somatic cell genetic material)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
200 ug/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
4 mg/kg
SEX/DURATION :
female 6-7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - other neonatal measures or effects
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
800 ug/kg
SEX/DURATION :
male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
500 ug/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - cytological changes (including somatic cell genetic material)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
800 ug/kg
SEX/DURATION :
male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Parenteral
DOSE :
1 mg/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Unscheduled DNA synthesis
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA damage
TYPE OF TEST :
Unscheduled DNA synthesis
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
DNA damage
TYPE OF TEST :
Cytogenetic analysis
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Dominant lethal test
TYPE OF TEST :
Sperm Morphology

MUTATION DATA

TYPE OF TEST :
Unscheduled DNA synthesis
TEST SYSTEM :
Mammal - species unspecified Kidney
DOSE/DURATION :
10 umol/L
REFERENCE :
JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76- Volume(issue)/page/year: 6,333,1980 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,269,1987 IARC Cancer Review:Human Limited Evidence IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,269,1987 IARC Cancer Review:Group 2A IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,269,1987 TOXICOLOGY REVIEW CRTXB2 CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- Volume(issue)/page/year: 1(1),93,1971 TOXICOLOGY REVIEW MIMDAL Minnesota Medicine. (Minnesota Medical Assoc., 2221 University Ave., SE, Suite 400, Minneapolis, MN 55414) V.1- 1918- Volume(issue)/page/year: 57,19,1974 TOXICOLOGY REVIEW JAMAAP JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- Volume(issue)/page/year: 172,1765,1960 TOXICOLOGY REVIEW 32XPAD "Teratology," Berry, C.L., and D.E. Poswillo, eds., New York, Springer, 1975 Volume(issue)/page/year: -,49,1975 TOXICOLOGY REVIEW CLPTAT Clinical Pharmacology and Therapeutics (St. Louis). (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63146) V.1- 1960- Volume(issue)/page/year: 5,480,1964 TOXICOLOGY REVIEW ADVPA3 Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. Volume(issue)/page/year: 4,263,1966 TOXICOLOGY REVIEW ARVPAX Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. Volume(issue)/page/year: 5,447,1965 TOXICOLOGY REVIEW BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 2,1055,1961 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-GERMANY;Skin;Carcinogen JAN 1993 OEL-SWITZERLAND;Carcinogen JAN 1993 OEL-SWITZERLAND;Skin;Carcinogen JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4741 No. of Facilities: 205 (estimated) No. of Industries: 1 No. of Occupations: 6 No. of Employees: 4565 (estimated) No. of Female Employees: 2036 (estimated)
毒理学数据:

口服-大鼠 LD50: 10 毫克/公斤; 口服-小鼠 LD50:10 毫克/公斤。

氮芥 MSDS

第一部分:化学品名称
化学品中文名称: 双(2-氯乙基)甲胺;氮芥
化学品英文名称: Bis-(2-chloroethyl)methylamine;Dichloramine
中文俗名或商品名:
Synonyms:
CAS No.: 51-75-2
分子式: C5H11Cl2N
分子量: 156.07
第二部分:成分/组成信息
             纯化学品   混合物
             化学品名称:双(2-氯乙基)甲胺;氮芥
有害物成分 含量 CAS No.
第三部分:危险性概述
危险性类别:
侵入途径: 吸入 食入 经皮吸收
健康危害: 本品属高毒类。吸入、摄入或经皮肤吸收后均可引起中毒。对人有致突变作用。人静脉注射0.4mg/kg,可迅速引起肠胃道症状,迟发性白细胞抑制。本品是一种强起疱剂和局部刺激剂。
环境危害: 对环境有危害,对水体可造成污染。
燃爆危险: 本品可燃,高毒。
第四部分:急救措施
皮肤接触: 用肥皂水及清水彻底冲洗。就医。
眼睛接触: 拉开眼睑,用流动清水冲洗15分钟。就医。
吸入: 脱离现场至空气新鲜处。就医。
食入: 误服者,饮适量温水,催吐。就医。
第五部分:消防措施
危险特性: 遇明火、高热可燃。受高热分解,放出有毒的烟气。
有害燃烧产物: 一氧化碳、二氧化碳、氮氧化物、氯化氢。
灭火方法及灭火剂: 消防人员必须佩戴过滤式防毒面具(全面罩)或隔离式呼吸器、穿全身防火防毒服,在上风向灭火。尽可能将容器从火场移至空旷处。喷水保持火场容器冷却,直至灭火结束。处在火场中的容器若已变色或从安全泄压装置中产生声音,必须马上撤离。灭火剂:泡沫、干粉、砂土。
消防员的个体防护:
禁止使用的灭火剂:
闪点(℃):
自燃温度(℃):
爆炸下限[%(V/V)]:
爆炸上限[%(V/V)]:
最小点火能(mJ):
爆燃点:
爆速:
最大燃爆压力(MPa):
建规火险分级:
第六部分:泄漏应急处理
应急处理: 疏散泄漏污染区人员至安全区,禁止无关人员进入污染区,建议应急处理人员戴自给式呼吸器,穿化学防护服。不要直接接触泄漏物,用砂土吸收,收集倒至空旷地方深埋。用水刷洗泄漏污染区,对污染地带进行通风。如大量泄漏,利用围堤收容,然后收集、转移、回收或无害处理后废弃。
第七部分:操作处置与储存
操作注意事项: 密闭操作,提供充分的局部排风。防止蒸气泄漏到工作场所空气中。操作人员必须经过专门培训,严格遵守操作规程。建议操作人员佩戴自吸过滤式防毒面具(全面罩),穿胶布防毒衣,戴橡胶手套。远离火种、热源,工作场所严禁吸烟。使用防爆型的通风系统和设备。在清除液体和蒸气前不能进行焊接、切割等作业。避免产生烟雾。避免与氧化剂接触。配备相应品种和数量的消防器材及泄漏应急处理设备。倒空的容器可能残留有害物。
储存注意事项: 储存于阴凉、干燥、通风良好的库房。远离火种、热源。防止阳光直射。包装必须密封,切勿受潮。应与氧化剂、食用化学品等分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有泄漏应急处理设备和合适的收容材料。
第八部分:接触控制/个体防护
最高容许浓度: 中 国 MAC:未制订标准前苏联 MAC:未制订标准美国TLV—TWA:未制订标准
监测方法:
工程控制: 严加密闭,提供充分的局部排风。尽可能机械化、自动化。
呼吸系统防护: 可能接触其蒸气时,佩戴防毒面具。紧急事态抢救或逃生时,应该佩戴自给式呼吸器。
眼睛防护: 戴化学安全防护眼镜。
身体防护: 穿相应的防护服。
手防护: 戴防化学品手套。
其他防护: 工作现场禁止吸烟、进食和饮水。工作后,淋浴更衣。保持良好的卫生习惯。
第九部分:理化特性
外观与性状: 液体。
pH:
熔点(℃): -60
沸点(℃): 75/1.33kPa
相对密度(水=1): 1.09(25℃)
相对蒸气密度(空气=1): 5.9
饱和蒸气压(kPa): 0.02/25℃
燃烧热(kJ/mol):
临界温度(℃):
临界压力(MPa):
辛醇/水分配系数的对数值:
闪点(℃):
引燃温度(℃):
爆炸上限%(V/V):
爆炸下限%(V/V):
分子式: C5H11Cl2N
分子量: 156.07
蒸发速率:
粘性:
溶解性: 微溶于水,可混溶于四氯化碳、二硫化碳。
主要用途: 主要用作抗癌药物及用于有机合成。
第十部分:稳定性和反应活性
稳定性: 在常温常压下 稳定
禁配物: 强氧化剂、水。
避免接触的条件: 接触潮气可分解。
聚合危害: 不能出现
分解产物: 一氧化碳、二氧化碳、氮氧化物、氯化氢。
第十一部分:毒理学资料
急性毒性: LD50:10mg/kg(大鼠经口);10mg/kg(小鼠经口);12mg/kg(兔经皮) LC50:
急性中毒:
慢性中毒:
亚急性和慢性毒性:
刺激性: 家兔经眼: 400μg ,重度刺激。
致敏性:
致突变性:
致畸性:
致癌性:
第十二部分:生态学资料
生态毒理毒性:
生物降解性:
非生物降解性:
生物富集或生物积累性:
第十三部分:废弃处置
废弃物性质:
废弃处置方法: 建议用控制焚烧法或安全掩埋法处置。破损容器禁止重新使用,要在规定场所掩埋。
废弃注意事项:
第十四部分:运输信息
危险货物编号:
UN编号:
包装标志:
包装类别:
包装方法:
运输注意事项: 储存于阴凉、通风仓间内;远离火种、热源。专人保管。操作现场不得吸烟、饮水、进食。防止受潮和雨淋。应与氧化剂、食用化工原料分开存放。不能与粮食、食物、种子、饲料、各种日用品混装、混运。搬运时要轻装轻卸,
RETCS号:
IMDG规则页码:
第十五部分:法规信息
国内化学品安全管理法规: 化学危险物品安全管理条例 (1987年2月17日国务院发布),化学危险物品安全管理条例实施细则 (化劳发[1992] 677号),工作场所安全使用化学品规定 ([1996]劳部发423号)等法规,针对化学危险品的安全使用、生产、储存、运输、装卸等方面均作了相应规定。
国际化学品安全管理法规:
第十六部分:其他信息
参考文献: 1.周国泰,化学危险品安全技术全书,化学工业出版社,1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编,化学品毒性法规环境数据手册,中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989
填表时间: 年月日
填表部门:
数据审核单位:
修改说明:
其他信息: 6
MSDS修改日期: 年月日

氮芥 海关数据

中国海关编码:2921194000

概述:
2921194000 N,N-二(2-氯乙基)甲胺。监管条件:3(两用物项和技术出口许可证)2(两用物项和技术出口许可证,两用物项和技术进口许可证)。增值税率:17.0%。退税率:9.0%。最低关税:6.5%。普通关税:30.0%
申报要素:
品名, 成分含量, 用途
监管条件:
3.两用物项和技术出口许可证2.两用物项和技术进口许可证
摘要/Summary:
2921194000 2-chloro-n-(2-chloroethyl)-n-methylethanamine。supervision conditions:3(export license for dual-use item and technologies)2(export license for dual-use item and technologies,import license for dual-use item and technologies)。VAT:17.0%。tax rebate rate:9.0%。MFN tarrif:6.5%。general tariff:30.0%

氮芥 分子结构与计算化学数据

分子结构数据

1、  摩尔折射率:38.63

2、  摩尔体积(cm3/mol):141.0

3、  等张比容(90.2K):333.6

4、  表面张力(dyne/cm):31.2

5、  极化率(10-24cm3):15.31

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:0

3.氢键受体数量:1

4.可旋转化学键数量:4

5.互变异构体数量:无

6.拓扑分子极性表面积3.2

7.重原子数量:8

8.表面电荷:0

9.复杂度:43.7

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

推荐供应商更多供应商>>